Viewing Study NCT04627012


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-30 @ 4:37 PM
Study NCT ID: NCT04627012
Status: COMPLETED
Last Update Posted: 2024-03-06
First Post: 2020-11-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module